These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5140806)

  • 1. [Rifamycin: progress in development of antiviral agents].
    Beker I
    Harefuah; 1971 Mar; 80(6):336-8. PubMed ID: 5140806
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reasons why rifampicin is not a clinically useful antiviral agent].
    Staehelin M
    Dtsch Med Wochenschr; 1970 Apr; 95(17):970. PubMed ID: 5439557
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitrachoma activity of rifamycin B and 8-O-acetylrifamycin S.
    Becker Y
    Nature; 1971 May; 231(5298):115-6. PubMed ID: 4930088
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampicin and viruses.
    Br Med J; 1969 Jun; 2(5657):588-9. PubMed ID: 5798465
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiviral agents].
    Amato Neto V; Barone AA
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Oct; 36(5):221-9. PubMed ID: 6176002
    [No Abstract]   [Full Text] [Related]  

  • 7. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
    Pallanza R; Arioli V; Furesz S; Bolzoni G
    Arzneimittelforschung; 1967 May; 17(5):529-34. PubMed ID: 5631580
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
    Dhople AM; Dimova V
    Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [First therapeutic applications of Rifampicine (Rifamycin AMP). Preliminary note].
    Monaldi V
    Arch Tisiol Mal Appar Respir; 1966 Nov; 21(11):863-6. PubMed ID: 5301816
    [No Abstract]   [Full Text] [Related]  

  • 11. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of rifamycin SV as a method of venous perfusion in tuberculotics with liver diseases].
    Zanotelli F
    Fracastoro; 1965; 58(6):427-38. PubMed ID: 5863724
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of rifamycin SV in surgery of the biliary tract].
    Lodigiani E
    Chir Ital; 1966 Apr; 18(2):222-37. PubMed ID: 5188277
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2.
    Fattinger K; Cattori V; Hagenbuch B; Meier PJ; Stieger B
    Hepatology; 2000 Jul; 32(1):82-6. PubMed ID: 10869292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current use for old antibacterial agents: polymyxins, rifampin, and aminoglycosides.
    Kaye D
    Infect Dis Clin North Am; 2004 Sep; 18(3):669-89, x. PubMed ID: 15308281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The therapeutic action of Rifampicin, a derivative of 3-(4-methyl-1-piperazinyl-iminomethyl)-rifamycin SV, in pulmonary tuberculosis].
    Lucchesi M; Pallotta G; Rossi P; Sbampato M
    Ann Ist Carlo Forlanini; 1967; 27(3):199-227. PubMed ID: 5602885
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.
    Goldberg SV; Hanson D; Peloquin CA
    Clin Infect Dis; 2003 Aug; 37(4):607-8. PubMed ID: 12905149
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanine green in man.
    Acocella G; Nicolis FB; Tenconi LT
    Gastroenterology; 1965 Nov; 49(5):521-5. PubMed ID: 5322057
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro bacteriological studies on rifamycin B diethylamide (rifamide).
    Pallanza R; Fürész S; Timbal MT; Carniti G
    Arzneimittelforschung; 1965 Jul; 15(7):800-2. PubMed ID: 5898682
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifapentine--a long-acting rifamycin for tuberculosis.
    Med Lett Drugs Ther; 1999 Feb; 41(1047):21-2. PubMed ID: 10076594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.